Exact Sciences
EXAS
#1945
Rank
NZ$14.17 B
Marketcap
$76.30
Share price
-2.89%
Change (1 day)
-31.63%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$1.79 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.75 Billion. a decrease over its 2023 earnings that were of -NZ$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$1.78 Billion435.08%
2023 -NZ$0.34 Billion-69.28%
2022 -NZ$1.08 Billion-25.55%
2021 -NZ$1.45 Billion1.68%
2020 -NZ$1.43 Billion271.17%
2019 -NZ$0.39 Billion58.99%
2018 -NZ$0.25 Billion20.89%
2017 -NZ$0.2 Billion-30.95%
2016 -NZ$0.29 Billion5.09%
2015 -NZ$0.28 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$80.86 Million
2011 -NZ$50.34 Million143.73%
2010 -NZ$20.66 Million27.85%
2009 -NZ$16.16 Million0.27%
2008 -NZ$16.12 Million-20.95%
2007 -NZ$20.39 Million-13.53%
2006 -NZ$23.58 Million-10.07%
2005 -NZ$26.22 Million-21.81%
2004 -NZ$33.53 Million-33.44%
2003 -NZ$50.37 Million-6.51%
2002 -NZ$53.88 Million17.95%
2001 -NZ$45.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.22 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$44.96 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$61.07 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.87 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France